This site is no longer maintained and is presented for archive purposes only
| Title: Inflammatory bowel disease: medical cost algorithms. | ||||
| Title Abreviation: J Clin Gastroenterol | Date of Pub: 1992 Jun | |||
| Author: Hay AR; Hay JW; | ||||
| Issue/Part/Supplement: 4 | Volume Issue: 14 | Pagination: 318-27 | ||
| MESH Headings: Algorithms (*); Colitis, Ulcerative (*EC/EP); Costs and Cost Analysis (MT); Crohn Disease (*EC/EP); Drug Therapy (EC); Health Care Costs (*SN); Human; Models, Econometric (*); Prevalence; Support, Non-U.S. Gov't; Surgery, Operative (EC); United States (EP); -AA-; | ||||
| Journal Title Code: IBG | Publication Type: JOURNAL ARTICLE | |||
| Date of Entry: 920723N | Entry Month: 9209 | |||
| Country: UNITED STATES | Index Priority: 2 | |||
| Language: Eng | Unique Identifier: 92299937 | |||
| Unique Identifier: 92299937 | ISSN: 0192-0790 | |||
| Abstract: In this study we describe medical cost estimates for the two major types of inflammatory bowel disease, Crohn's disease and ulcerative colitis, using a literature-based medical decision algorithm costing methodology. Surgery and inpatient costs were estimated to account for roughly half of inflammatory bowel disease medical costs. Outpatient medical care represented only 3.0-7.1% of average cost of medical care for inflammatory bowel disease; initial diagnostic workups were only 1.5-7.8% of medical costs. Long-term complications were estimated to average $439 for ulcerative colitis, nearly twice the average for Crohn's disease. Medications averaged about 10% of total costs. The average annual medical cost per patient with Crohn's disease was estimated at $6,561 (1990 U.S. dollars). The total annual medical costs for U.S. Crohn's disease patients in 1990 was estimated at $1.0-1.2 billion. The average annual medical cost per patient with ulcerative colitis was estimated at $1,488. The total annual medical costs for U.S. patients with ulcerative colitis in 1990 was estimated at $0.4-0.6 billion. | ||||
| Abstract By: Author | ||||
| Address: Department of Pharmaceutical Economics and Policy, University of Southern California, Los Angeles 90033. | ||||